{"title":"酿酒酵母高效生产7-脱氢胆固醇的途径重构","authors":"Yuchen Han, Huayi Gao, Shuo Wang, Haiyan Ju, Ran Ge, Chaoyou Xue, Weidong Liu, Xiaolong Jiang, Wuyuan Zhang","doi":"10.1021/acssynbio.5c00032","DOIUrl":null,"url":null,"abstract":"<p><p>7-Dehydrocholesterol (7-DHC) is a subcutaneous sterol and a precursor to various active vitamin D<sub>3</sub>. Here, a <i>Saccharomyces cerevisiae</i> strain equipped with the <i>de novo</i> biosynthetic pathway for 7-DHC was constructed. 109.0 mg L<sup>-1</sup> of 7-DHC was achieved initially by introducing heterologous 24-dehydrocholesterol reductase (<i>DHCR24</i>) and overexpressing vital enzymes. Following these modifications, the dynamic regulation of the ergosterol pathway and multicopy expression of <i>DHCR24</i> resulted in an 86.3% increase in the 7-DHC titer. Subsequently, the effects of several organic solvents and surfactants on 7-DHC production were also explored. The addition of ε-polylysine increased the titer of 7-DHC by 99.1%. Finally, by assembling the pathway in peroxisomes and rebalancing the redox levels, the 7-DHC titer reached 517.4 mg L<sup>-1</sup> in shake flasks. Scale-up fermentation with a 5 L bioreactor demonstrated that 3.26 g L<sup>-1</sup> of 7-DHC was produced. The pathway refactoring strategy provides efficient production of 7-DHC in a sustainable manner.</p>","PeriodicalId":26,"journal":{"name":"ACS Synthetic Biology","volume":" ","pages":"2609-2618"},"PeriodicalIF":3.7000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Pathway Refactoring for Efficient 7-Dehydrocholesterol Production in <i>Saccharomyces cerevisiae</i>.\",\"authors\":\"Yuchen Han, Huayi Gao, Shuo Wang, Haiyan Ju, Ran Ge, Chaoyou Xue, Weidong Liu, Xiaolong Jiang, Wuyuan Zhang\",\"doi\":\"10.1021/acssynbio.5c00032\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>7-Dehydrocholesterol (7-DHC) is a subcutaneous sterol and a precursor to various active vitamin D<sub>3</sub>. Here, a <i>Saccharomyces cerevisiae</i> strain equipped with the <i>de novo</i> biosynthetic pathway for 7-DHC was constructed. 109.0 mg L<sup>-1</sup> of 7-DHC was achieved initially by introducing heterologous 24-dehydrocholesterol reductase (<i>DHCR24</i>) and overexpressing vital enzymes. Following these modifications, the dynamic regulation of the ergosterol pathway and multicopy expression of <i>DHCR24</i> resulted in an 86.3% increase in the 7-DHC titer. Subsequently, the effects of several organic solvents and surfactants on 7-DHC production were also explored. The addition of ε-polylysine increased the titer of 7-DHC by 99.1%. Finally, by assembling the pathway in peroxisomes and rebalancing the redox levels, the 7-DHC titer reached 517.4 mg L<sup>-1</sup> in shake flasks. Scale-up fermentation with a 5 L bioreactor demonstrated that 3.26 g L<sup>-1</sup> of 7-DHC was produced. The pathway refactoring strategy provides efficient production of 7-DHC in a sustainable manner.</p>\",\"PeriodicalId\":26,\"journal\":{\"name\":\"ACS Synthetic Biology\",\"volume\":\" \",\"pages\":\"2609-2618\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Synthetic Biology\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1021/acssynbio.5c00032\",\"RegionNum\":2,\"RegionCategory\":\"生物学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/27 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMICAL RESEARCH METHODS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Synthetic Biology","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1021/acssynbio.5c00032","RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/27 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0
摘要
7-脱氢胆固醇(7-DHC)是一种皮下固醇,是多种活性维生素D3的前体。本文构建了一株具有7-DHC生物合成新途径的酿酒酵母。通过引入异源24-脱氢胆固醇还原酶(DHCR24)并过表达重要酶,初步获得109.0 mg L-1的7-DHC。经过这些修饰,麦角甾醇通路的动态调控和DHCR24的多拷贝表达导致7-DHC滴度升高86.3%。随后,探讨了几种有机溶剂和表面活性剂对7-DHC合成的影响。ε-聚赖氨酸的添加使7-DHC的效价提高了99.1%。最后,通过在过氧化物酶体中组装途径并重新平衡氧化还原水平,在摇瓶中7-DHC滴度达到517.4 mg L-1。5 L生物反应器放大发酵,7-DHC产量为3.26 g L-1。路径重构策略以可持续的方式提供了7-DHC的高效生产。
Pathway Refactoring for Efficient 7-Dehydrocholesterol Production in Saccharomyces cerevisiae.
7-Dehydrocholesterol (7-DHC) is a subcutaneous sterol and a precursor to various active vitamin D3. Here, a Saccharomyces cerevisiae strain equipped with the de novo biosynthetic pathway for 7-DHC was constructed. 109.0 mg L-1 of 7-DHC was achieved initially by introducing heterologous 24-dehydrocholesterol reductase (DHCR24) and overexpressing vital enzymes. Following these modifications, the dynamic regulation of the ergosterol pathway and multicopy expression of DHCR24 resulted in an 86.3% increase in the 7-DHC titer. Subsequently, the effects of several organic solvents and surfactants on 7-DHC production were also explored. The addition of ε-polylysine increased the titer of 7-DHC by 99.1%. Finally, by assembling the pathway in peroxisomes and rebalancing the redox levels, the 7-DHC titer reached 517.4 mg L-1 in shake flasks. Scale-up fermentation with a 5 L bioreactor demonstrated that 3.26 g L-1 of 7-DHC was produced. The pathway refactoring strategy provides efficient production of 7-DHC in a sustainable manner.
期刊介绍:
The journal is particularly interested in studies on the design and synthesis of new genetic circuits and gene products; computational methods in the design of systems; and integrative applied approaches to understanding disease and metabolism.
Topics may include, but are not limited to:
Design and optimization of genetic systems
Genetic circuit design and their principles for their organization into programs
Computational methods to aid the design of genetic systems
Experimental methods to quantify genetic parts, circuits, and metabolic fluxes
Genetic parts libraries: their creation, analysis, and ontological representation
Protein engineering including computational design
Metabolic engineering and cellular manufacturing, including biomass conversion
Natural product access, engineering, and production
Creative and innovative applications of cellular programming
Medical applications, tissue engineering, and the programming of therapeutic cells
Minimal cell design and construction
Genomics and genome replacement strategies
Viral engineering
Automated and robotic assembly platforms for synthetic biology
DNA synthesis methodologies
Metagenomics and synthetic metagenomic analysis
Bioinformatics applied to gene discovery, chemoinformatics, and pathway construction
Gene optimization
Methods for genome-scale measurements of transcription and metabolomics
Systems biology and methods to integrate multiple data sources
in vitro and cell-free synthetic biology and molecular programming
Nucleic acid engineering.